Why Is Esperion Therapeutics (ESPR) Up 28.6% Since Last Earnings Report?

It has been about a month since the last earnings report for Esperion Therapeutics (ESPR) . Shares have added about 28.6% in that time frame, outperforming the S&P 500. It turns out, estimates review have trended downward during the past month. How Have Estimates Been Moving Since Then? The consensus estimate has shifted -25.93% due to these changes. VGM Scores Will the recent positive trend continue leading up to its next earnings release, or is Esperion Therapeutics due for a pullback? Before we dive into ...